OTLK insider buying
Every open-market purchase of Outlook Therapeutics, Inc. (OTLK) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$7.90M
Insiders buying (12m)5
Purchases on record7
Last purchase filedAug 14, 2026
In the last 12 months, 5 insiders of Outlook Therapeutics, Inc. bought $7.90M of OTLK stock on the open market in 7 reported purchases. The most recent was filed on Aug 14, 2026: Sukhtian Ghiath M. +1 (Director, 10% Owner) bought 2,525,252 shares at $0.99, worth $2.50M. The largest purchase on record here is $5.04M by GMS Ventures & Investments +1 on May 28, 2026.
Get the next OTLK insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll OTLK insider purchases
| Filed | Insider | Value | Shares | Price | Stake | Trade | |
|---|---|---|---|---|---|---|---|
| Aug 14 | Sukhtian Ghiath M. +1Director, 10% Owner | $2.50M | 2,525,252 | $0.99 | +11% | Aug 12 | SEC |
| Jul 29 | Sukhtian Faisal GhiathDirector | $100.17K | 95,398 | $1.05 | +76% | Jul 29 | SEC |
| Jun 3 | Haddadin Yezan MuntherDirector | $24.07K | 29,000 | $0.83 | +78% | Jun 2 | SEC |
| Jun 1 | GMS Ventures & Investments +1Director, 10% Owner | $5.04M | 8,539,709 | $0.59 | +63% | May 28 | SEC |
| May 27 | Sukhtian Faisal GhiathDirector | $50.09K | 122,174 | $0.41 | >+999% | May 27 | SEC |
| May 27 | Haddadin Yezan MuntherDirector | $14.96K | 34,000 | $0.44 | >+999% | May 26 | SEC |
| May 27 | Hilzinger Kurt JDirector | $176K | 400,000 | $0.44 | >+999% | May 26 | SEC |